Get the Stockscreener App
26.01
0.73%
-0.19
After Hours:
26.05
0.04
+0.15%
Ceribell Inc stock is traded at $26.01, with a volume of 187.84K.
It is down -0.73% in the last 24 hours and up +0.00% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$26.20
Open:
$26.25
24h Volume:
187.84K
Relative Volume:
3.05
Market Cap:
$926.20M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.76%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$25.61
$26.48
1-Week Range:
$25.02
$26.90
52-Week Range:
$24.10
$27.71
Ceribell Inc Stock (CBLL) Company Profile
Ceribell Inc Stock (CBLL) Latest News
A&O Shearman advises on initial public offering of Ceribell, Inc. - A&O Shearman
Ceribell’s stock soars 36% in trading debut after pricing IPO at top of range - MSN
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 - WV News
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell: An Interesting EEG Play Going Public (NASDAQ:CBLL) - Seeking Alpha
TPG GP A, LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell EEG system linked to improved patient outcomes - Investing.com India
Ceribell EEG system linked to improved patient outcomes By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock - Investing.com
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG - PR Newswire
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PR Newswire
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO - Fierce Biotech
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
CeriBell (NASDAQ: CBLL) Stock Soars On Debut Trading: Here are Key Drivers - DRP Journal
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN
CeriBell, EEG developer, sees stock rally 35% following $180M IPO - MSN
CeriBell Goes Public in Rare Medical-Device IPO - The Wall Street Journal
Latham & Watkins Advises CeriBell on Upsized IPO - ILW.com
CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq - Fast Company
Ceribell begins trading with upsized IPO - BioWorld Online
CeriBell, Inc. Rings the Closing Bell - Nasdaq
Ceribell Up 49% in Debut After Upsized IPO - MarketWatch
Neurotech company CeriBell prices $180.3M IPO - Mass Device
CeriBell, EEG developer, sees stock rally 35% following $180M IPO (NASDAQ:CBLL) - Seeking Alpha
Ceribell Opens At $23.26, IPO Priced At $17 By Investing.com - Investing.com Australia
CeriBell Releases Price Of Upsized Initial Public Offering - MPO-mag
CeriBell prices IPO at $17 per share - MSN
Upstream Bio, two other U.S. biotech startups price IPOs as healthcare listings rise - Reuters
CBLL IPO NewsSeizure diagnostic company CeriBell prices IPO at $17, the high end of the upwardly revised range - Renaissance Capital
CeriBell Shares Set for Trading Debut After Pricing IPO at High End of Views - MarketWatch
CeriBell Prices Upsized 10.61M Share IPO at $17/sh - Investing.com India
CeriBell Prices Upsized 10.61M Share IPO at $17/sh By Investing.com - Investing.com Canada
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering - StockTitan
TPG-backed CeriBell seeks up to $578 million valuation in upsized US IPO - MSN
Preview: Ceribell, Inc Set To IPO Tomorrow - Benzinga
CeriBell seeks up to $578 million valuation in upsized US IPO - WTAQ
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs - MSN
TPG-backed CeriBell seeks up to $578 mln valuation in upsized US IPO - Reuters
CeriBell, Inc Files for Upsized 10.6M Share IPO at a Higher $16-$17/sh Price Range - Investing.com India
CeriBell seeks up to $578 mln valuation in upsized US IPO - XM
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs (Pending:UPB) - Seeking Alpha
Ceribell Seeks Public Debut with $101M IPO Amid Medtech IPO Struggles - MD+DI
Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO - Fierce Biotech
CeriBell, Inc Files for 6.7M Share IPO at $14-$16/sh - Investing.com
New technology helps with seizure detection - KING5.com
New tech helps with early seizure detectionNew Day NW - KING5.com
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.23%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):